Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models
Endocrinology · 17.04.2023 · 164 (6)
DOI: 10.1210/endocr/bqad061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 12.04.2023. Verfasst von Briaunna M N Minor und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Lymphangioleiomyomatosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease caused by smooth muscle cell-like tumors containing tuberous sclerosis (TSC) gene mutations and found almost exclusively in females. Patient studies suggest LAM progression is estrogen dependent, an observation supported by in vivo mouse models. However, in vitro data using TSC-null cell lines demonstrate modest estradiol (E2) responses, suggesting E2 effects in vivo may involve pathways independent of direct tumor stimulation. We previously reported tumor-dependent neutrophil expansion and promotion of TSC2-null tumor growth in an E2-sensitive LAM mouse model. We therefore hypothesized that E2 stimulates tumor growth in part by promoting neutrophil production. Here we report that E2-enhanced lung colonization of TSC2-null cells is indeed dependent on neutrophils. We demonstrate that E2 induces granulopoiesis via estrogen receptor α in male and female bone marrow cultures. With our novel TSC2-null mouse myometrial cell line, we show that factors released from these cells drive E2-sensitive neutrophil production. Last, we analyzed single-cell RNA sequencing data from LAM patients and demonstrate the presence of tumor-activated neutrophils. Our data suggest a powerful positive feedback loop whereby E2 and tumor factors induce neutrophil expansion, which in turn intensifies tumor growth and production of neutrophil-stimulating factors, resulting in continued TSC2-null tumor growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Division of Comparative Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
- Division of Hematology and Oncology, Department of Internal Medicine, UTSW Medical Center, Dallas, TX 75390, USA.
- Divisions of Pulmonary Biology & Biomedical Informatics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
ORCID-Profile: Stephen R Hammes
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
- Foundation for the National Institutes of Health
- National Institutes of Health
Zitieren
APA
Minor, B. M. N., LeMoine, D., Seger, C., Gibbons, E., Koudouovoh, J., Taya, M., Kurtz, D., Xu, Y., & Hammes, S. R. (2023). Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models. Endocrinology, 164(6). https://doi.org/10.1210/endocr/bqad061
Vancouver
Minor BMN, LeMoine D, Seger C, Gibbons E, Koudouovoh J, Taya M, et al. Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models. Endocrinology. 2023;164(6). doi:10.1210/endocr/bqad061
BibTeX
@article{Minor2023,
author = {Minor, Briaunna M N and LeMoine, Dana and Seger, Christina and Gibbons, Erin and Koudouovoh, Jules and Taya, Manisha and Kurtz, Daniel and Xu, Yan and Hammes, Stephen R},
title = {Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models},
journal = {Endocrinology},
year = {2023},
volume = {164},
number = {6},
doi = {10.1210/endocr/bqad061}
}
EUVIMED